Sandoz breaks free: A new dawn for independent generic pharmaceuticals
SWITZERLAND —Novartis, the parent company of Sandoz, has successfully completed the spinoff of...
Read More
Tag: Sandoz
Sandoz and Samsung Bioepis join forces to boost biosimilar market and enhance healthcare access
SOUTH KOREA — Novartis’ generic drugs division, Sandoz, has forged a strategic collaboration...
Read More
Sandoz secures landmark FDA approval for biosimilar of Biogen’s Tysabri
USA — In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has given its nod to...
Read More
Sandoz to boost biosimilars production capacity with US$90 million investment in Biosimilar Technical Development Center
SLOVENIA —In an impressive move to bolster its biosimilar pipeline, Sandoz is set to build a...
Read More
Sandoz launches biosimilar version of AbbVie’s Humira, intensifying U.S. competition in arthritis treatment
SWITZERLAND — Sandoz, the Swiss drugmaker and subsidiary of Novartis, announced on Saturday the...
Read More
Novartis unveils new Board Members for Sandoz spin-off, reinforcing strategic focus
SWITZERLAND — Novartis, a leading pharmaceutical company based in Basel, Switzerland, has...
Read More
Evotec and Sandoz forge a strategic partnership to accelerate biosimilars development
GERMANY — Evotec, along with its subsidiary Just – Evotec Biologics, Inc., based in Seattle,...
Read More
Sandoz receives FDA approval for high-strength Humira biosimilar
SWITZERLAND — Sandoz, a global leader in generic pharmaceuticals and biosimilars, has received...
Read More
Sandoz seeks to keep identity of CMO involved in tainted antibiotic under wraps
SWITZERLAND — Pharmaceutical experts are raising concerns over Sandoz’s refusal to reveal...
Read More
Sandoz strengthens position in Slovenia with US$400 million manufacturing plant
SLOVENIA — Sandoz, a generics manufacturer, has recently committed approximately US$400 million to...
Read More
Novartis’ Sandoz and Ibnsina Pharma ink deal to promote the safe use of OTC medications
EGYPT – Sandoz Egypt Pharma, a division of the Novartis Group, and Ibnsina Pharma have signed a...
Read More
Sandoz announces new global ‘Act4Biosimilars’ initiative, to increase adoption by at least 30%
SWITZERLAND – Sandoz, a global leader in generic and biosimilar medicines, has announced the...
Read More
LATEST DIGITAL MAGAZINE
